LECROLYN

This brand name is authorized in Estonia, Finland, Lithuania, Netherlands, Poland, Romania, South Africa.

Active ingredients

The drug LECROLYN contains one active pharmaceutical ingredient (API):

1	Cromoglicic acid UNII Q2WXR1I0PK - CROMOLYN SODIUM
	Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.
	Read more about Cromoglicic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GX01	Cromoglicic acid	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1001631, 1111712, 1640359, 1640360, 1640371, 1736614
FI	Lääkealan turvallisuus- ja kehittämiskeskus	012869, 012883, 012889, 012911, 063698, 105812
LT	Valstybinė vaistų kontrolės tarnyba	1008186, 1008187, 1072793, 1076277, 1076278, 1080874, 1081748, 1085744
PL	Rejestru Produktów Leczniczych	100394450
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64872001, W64872002, W64872003, W64872004
ZA	Health Products Regulatory Authority	31/15.4/0320, 31/15.4/0321, 31/15.4/0322, 31/15.4/0323